Nursing intervention on decreased cardiac output related to structural disorders secondary to cardiomyopathy or dysrhythmia
Answers
Answered by
0
Patients are usually referred to the Hypertrophic Cardiomyopathy Program at the Massachusetts General Hospital Corrigan Minehan Heart Center in Boston by their primary care physician or cardiologist because of cardiac symptoms, a heart murmur, or an abnormal ECG or echocardiogram, or because a family member has hypertrophic cardiomyopathy. After a personal and family history and physical examination, physicians may recommend further testing through any of the following procedures:
EchocardiographyHolter monitoringExercise stress testingMagnetic resonance imaging (MRI)
The Mass General Hospital cardiac ultrasound and radiology departments use state-of-the-art equipment for their diagnostic studies, which are interpreted by experts in the evaluation of hypertrophic cardiomyopathy.
For patients with hypertrophic cardiomyopathy, there are a number of risk factors which may place them at a higher-than-average risk of sudden death. For every patient, Corrigan Minehan Heart Center physicians determine whether any of these risk factors are present. Some patients are candidates for placement of an implantable cardioverter defibrillator (ICD). The Hypertrophic Cardiomyopathy Program includes arrhythmia specialists who advise patients as to whether an ICD should be placed.
A Comprehensive Treatment Plan
Our Doctors
Aaron L. Baggish, MDMichael A. Fifer, MDRobert E. Gerszten, MDTheofanie Mela, MDDanita M. Yoerger Sanborn, MD, MSCGus J. Vlahakes, MD
The treatment for hypertrophic cardiomyopathy depends on the severity of symptoms and the results of testing. Although there is currently no cure for hypertrophic cardiomyopathy, physicians at the Corrigan Minehan Heart Center offer a number of medications and procedures to favorably affect symptoms and the course of the disease:
For some patients who have hypertrophic cardiomyopathy, but do not have cardiac symptoms, no treatment is necessaryFor patients with symptoms, the first line of treatment is medical therapyFor patients with hypertrophic obstructive cardiomyopathy who have symptoms that cannot be controlled with medical therapy, we offer alcohol septal ablation or septal myectomyMany patients with hypertrophic cardiomyopathy have arrhythmias such as atrial fibrillation, atrial flutter or ventricular tachycardia. Arrhythmia specialists are available for consultation on medications, ICD or pacemaker placement and other procedure
Family Screening
Hypertrophic cardiomyopathy is, in many cases, an inherited genetic disease. Children, siblings, and parents of patients with hypertrophic cardiomyopathy may undergo screening with ECGs and echocardiograms to determine whether they also have hypertrophic cardiomyopathy. Genetic screening with a blood test is also available. The Hypertrophic Cardiomyopathy Program offers expertise in cardiac genetics for counseling families of patients with this condition.
Innovative Research
Hypertrophic cardiomyopathy experts collaborate to make treatment recommendations based on leading clinical cardiovascular research. Our patients have the opportunity to participate in clinical trials, including potential new treatments for hypertrophic cardiomyopathy. These research efforts influence the medical community, and our physicians often publish their results in distinguished academic journals.
EchocardiographyHolter monitoringExercise stress testingMagnetic resonance imaging (MRI)
The Mass General Hospital cardiac ultrasound and radiology departments use state-of-the-art equipment for their diagnostic studies, which are interpreted by experts in the evaluation of hypertrophic cardiomyopathy.
For patients with hypertrophic cardiomyopathy, there are a number of risk factors which may place them at a higher-than-average risk of sudden death. For every patient, Corrigan Minehan Heart Center physicians determine whether any of these risk factors are present. Some patients are candidates for placement of an implantable cardioverter defibrillator (ICD). The Hypertrophic Cardiomyopathy Program includes arrhythmia specialists who advise patients as to whether an ICD should be placed.
A Comprehensive Treatment Plan
Our Doctors
Aaron L. Baggish, MDMichael A. Fifer, MDRobert E. Gerszten, MDTheofanie Mela, MDDanita M. Yoerger Sanborn, MD, MSCGus J. Vlahakes, MD
The treatment for hypertrophic cardiomyopathy depends on the severity of symptoms and the results of testing. Although there is currently no cure for hypertrophic cardiomyopathy, physicians at the Corrigan Minehan Heart Center offer a number of medications and procedures to favorably affect symptoms and the course of the disease:
For some patients who have hypertrophic cardiomyopathy, but do not have cardiac symptoms, no treatment is necessaryFor patients with symptoms, the first line of treatment is medical therapyFor patients with hypertrophic obstructive cardiomyopathy who have symptoms that cannot be controlled with medical therapy, we offer alcohol septal ablation or septal myectomyMany patients with hypertrophic cardiomyopathy have arrhythmias such as atrial fibrillation, atrial flutter or ventricular tachycardia. Arrhythmia specialists are available for consultation on medications, ICD or pacemaker placement and other procedure
Family Screening
Hypertrophic cardiomyopathy is, in many cases, an inherited genetic disease. Children, siblings, and parents of patients with hypertrophic cardiomyopathy may undergo screening with ECGs and echocardiograms to determine whether they also have hypertrophic cardiomyopathy. Genetic screening with a blood test is also available. The Hypertrophic Cardiomyopathy Program offers expertise in cardiac genetics for counseling families of patients with this condition.
Innovative Research
Hypertrophic cardiomyopathy experts collaborate to make treatment recommendations based on leading clinical cardiovascular research. Our patients have the opportunity to participate in clinical trials, including potential new treatments for hypertrophic cardiomyopathy. These research efforts influence the medical community, and our physicians often publish their results in distinguished academic journals.
Similar questions